Elanco Animal Health (ELAN) Long-Term Investments (2017 - 2018)
Elanco Animal Health's (ELAN) quarterly Long-Term Investments came in at $15.3 million in Q4 2018, up 24.39% year-on-year from $12.3 million in Q4 2017, and up 2.68% quarter-over-quarter from $14.9 million in Q3 2018.
Elanco Animal Health (ELAN) Long-Term Investments (2017 - 2018) Analysis & Trends
Elanco Animal Health has disclosed Long-Term Investments across 2 years of filings, most recently posting $15.3 million for Q4 2018.
- Long-Term Investments for Q4 2018 came in at $15.3 million, up 24.39% year-over-year; the trailing twelve-month figure through Dec 2018 was $15.3 million (up 24.39% YoY), and the FY2018 annual result was $15.3 million, up 24.39% from the prior year.
- Long-Term Investments came in at $15.3 million for Q4 2018 at Elanco Animal Health, up from $14.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $15.3 million in Q4 2018 to a low of $12.3 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 15.30 Mn |
| Sep 30, 2018 | 14.90 Mn |
| Dec 31, 2017 | 12.30 Mn |